glp-1 expression Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies Glucagon-like peptide 1 receptor agonists

Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomised clinical trials

Researchers at the University of Pennsylvania compared GLP-1 medications with "other antidiabetic medications" and found that "GLP-1 drug use was associated with a higher overall risk of alopecia over an average follow-up of 2.7 years" in the study, published Wednesday, July 22 in The BMJ

This metabolic upregulation typically stabilizes after the first month as your body establishes a new baseline for energy expenditure

Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockade

J Manag Care Spec Pharm